Combating antibiotic resistance: Baylor researcher’s new strategy

A new strategy to combat antibiotic resistance has emerged from a study led by researchers at Baylor College of Medicine. Published in the journal Molecular Cell, the report reveals for the first time how bacteria evolve mutations that confer antibiotic resistance and that this process can be inhibited with FDA-approved drug edaravone. "Antibiotic resistance is one of ["]

The post Combating antibiotic resistance: Baylor researcher's new strategy appeared first on Outbreak News Today.